Trial · NCT00326183
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Participants With 1 or More Serious Vaccine-Related Adverse Experiences | Arm 1: VAQTA™ | 0 | participants | ||
| Participants With 1 or More Serious Vaccine-Related Adverse Experiences | Arm 2: VAQTA™ +ProQuad™ | 1 | participants | ||
| Participants With 1 or More Systemic Adverse Experiences | Arm 1: VAQTA™ | 782 | participants | ||
| Participants With 1 or More Systemic Adverse Experiences | Arm 2: VAQTA™ +ProQuad™ | 197 | participants | ||
| Participants With 1 or More Injection-Site Adverse Experiences | Arm 1: VAQTA™ | 701 | participants | ||
| Participants With 1 or More Injection-Site Adverse Experiences | Arm 2: VAQTA™ +ProQuad™ | 164 | participants | ||
| Participants With Measles-Like Rash After First Vaccination | Arm 2: VAQTA™ +ProQuad™ | 13 | participants | ||
| Participants With Measles-Like Rash After Second Vaccination | Arm 2: VAQTA™ +ProQuad™ | 5 | participants | ||
| Participants With Mumps-Like Symptoms After First Vaccination | Arm 2: VAQTA™ +ProQuad™ | 0 | participants | ||
| Participants With Mumps-Like Symptoms After Second Vaccination | Arm 2: VAQTA™ +ProQuad™ | 0 | participants | ||
| Participants With Rubella-Like Rash After First Vaccination | Arm 2: VAQTA™ +ProQuad™ | 1 | participants | ||
| Participants With Rubella-Like Rash After Second Vaccination | Arm 2: VAQTA™ +ProQuad™ | 0 | participants | ||
| Participants With Varicella/Zoster-Like Rash After First Vaccination | Arm 2: VAQTA™ +ProQuad™ | 0 | participants | ||
| Participants With Varicella/Zoster-Like Rash After Second Vaccination | Arm 2: VAQTA™ +ProQuad™ | 0 | participants | ||
| Participants With Elevated Temperature (>=102.2F/39.0C) | Arm 1: VAQTA™ | 56 | participants | ||
| Participants With Elevated Temperature (>=102.2F/39.0C) | Arm 2: VAQTA™ +ProQuad™ | 13 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00326183/results